Yegor Tryliskyy

Yegor Tryliskyy

Auto-generated profile, based on publicly available information

Yegor Tryliskyy

Southmead Hospital, Bristol, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2022 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
YTYegor Tryliskyy
Yegor Tryliskyy
CWChee Siong Wong
Chee Siong Wong
IDIvanna Demykhova
Ivanna Demykhova
VTVolodymyr Tyselskyi
Volodymyr Tyselskyi
AKAndrii Kebkalo
Andrii Kebkalo
VPVitaliy Poylin
Vitaliy Poylin

8 November 2021 in Hernia
Verified
Journal Article
Closed access
PDF file
YTY. Tryliskyy
Y. Tryliskyy
CWC. S. Wong
C. S. Wong
IDI. Demykhova
I. Demykhova
VTV. Tyselskyi
V. Tyselskyi
AKA. Kebkalo
A. Kebkalo
DPD. J. Pournaras
D. J. Pournaras

30 November 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
CWChee Siong Wong
Chee Siong Wong
SZShafquat Zaman
Shafquat Zaman
KSKoushik Siddiraju
Koushik Siddiraju
ASArchana Sellvaraj
Archana Sellvaraj
TGTariq Ghattas
Tariq Ghattas
YTYegor Tryliskyy
Yegor Tryliskyy
Immunonutrition (IMN) modulates the activity of the immune system. However, the effects of IMN on cancer patients following colorectal surgery is still lacking. We performed a systematic review and meta-analysis to evaluate the outcomes of IMN in patients undergoing laparoscopic versus open colorectal surgery. A systematic search of multiple electronic data sources was conducted in accordance with PRISMA guidelines and included MEDLINE via PubMed, EMBASE, Scopus, and Web of Science. All eligible studies reporting comparative outcomes of immunonutrition in colorectal surgery were included. Subgroup analysis of outcomes of interest was performed and data were analysed using Review Manager (RevMan) Version 5.4.1. Nine randomised controlled trials (RCTs) were identified. The final pooled analysis included 1199 patients (592 IMN group and 592 control group). Of these, 55.3 % (655/1184) had open colorectal surgery (OG) and 44.7 % (529/1184) underwent laparoscopic colorectal surgery (LG). IMN reduced the risk of wound infection significantly in the OG [risk ratio (RR) 0.48, 95 % confidence interval (CI) 0.32 to 0.72; p = 0.0005)] and the open and laparoscopic group (OLG) [RR 0.33, 95 % CI 0.15 to 0.76; p = 0.008]. Moreover, IMN was also associated with a significantly shorter length of hospital stay (MD - 2.37 days, 95 % CI - 3.39 to -1.36; p < 0.0001) in the OG. Other post-operative morbidities (anastomotic leak and ileus) and mortality outcomes in the OG, LG, and OLG were comparable. Pre-operative IMN could reduce the wound infection rate and shorten length of hospital stay in patients following elective colorectal surgery. The benefit of these improved clinical outcomes could be further evaluated with a cost-benefit analysis. IMN should be recommended as nutritional adjunct in the Enhanced Recovery after Surgery (ERAS) pathway following colorectal surgery.

20 December 2022 in Polish Journal of Surgery
Verified
Journal Article
Closed access
VTVolodymyr Tyselskyi
Volodymyr Tyselskyi
YTYegor Tryliskyy
Yegor Tryliskyy
VPVitaliy Poylin
Vitaliy Poylin
AKAndrey Kebkalo
Andrey Kebkalo
Introduction: Venous thromboembolism (VTE) is common after bariatric surgery, and extended prophylaxis is generally recommended. Low-molecular-weight heparin (LMWH) is the most common agent, but it requires patients to be trained to self-inject and is expensive. Rivaroxaban is an oral daily formulation approved for VTE prophylaxis after orthopaedic surgery. The efficacy and safety of rivaroxaban have been confirmed in major gastrointestinal resections by several observational studies. We report a single-centre experience of using rivaroxaban as an agent for VTE prophylaxis in bariatric surgery. Materials and methods: We performed a prospective cohort study assessing the safety and efficacy of rivaroxaban as a medication for VTE prophylaxis in patients undergoing bariatric surgery in a single centre in Kyiv, Ukraine. The patients undergoing a major bariatric procedure received perioperative VTE prophylaxis with subcutaneous LMWH and were then switched to rivaroxaban for a total of 30 days starting on the 4th postoperative day. Thromboprophylaxis was performed in accordance with the VTE risks derived from the Caprini score. On the 3rd, 30th and 60th days after the operation, the patients underwent ultrasound examination of the portal vein, as well as the veins of the lower extremities. Telephone interviews were conducted 30 and 60 days after the surgery to evaluate the presence of complaints which may indicate VTE and to assess the patients’ compliance with the regimen and satisfaction. The outcomes of the study were incidence of VTE and adverse events related to rivaroxaban administration. Results: A total of 110 patients were included in the study from July 2019 to May 2021. The average age of the patients was 43.6 years, and the average preoperative BMI was 55 (35 to 75). Of these patients, 107 (97.3%) underwent laparoscopic intervention, while 3 (2.7%) underwent laparotomy. Eighty-four patients underwent sleeve gastrectomy, and 26 underwent other procedures, including bypass surgery. The average calculated risk of thromboembolic event was 5–6% based on the Caprini score. All patients were treated with extended prophylaxis with rivaroxaban. The average follow-up period for patients was 6 months. There was no clinical or radiological evidence of thromboembolic complications in the study cohort. The overall complication rate was 7.2%; only 1 patient (0.9%) developed subcutaneous haematoma associated with rivaroxaban which did not require intervention. Conclusion: Extended postoperative prophylaxis with rivaroxaban is safe and effective in preventing thromboembolic complications in patients undergoing bariatric surgery. It is preferred by patients and further studies should be considered to evaluate its use in bariatric surgery.

1 January 2024 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
YTYegor Tryliskyy
Yegor Tryliskyy
IDIvanna Demykhova
Ivanna Demykhova
AKAndrii Kebkalo
Andrii Kebkalo
DPDimitri J. Pournaras
Dimitri J. Pournaras
Introduction: Minimally invasive surgery for ventral hernia repair (MIS-VHR) with mesh in retromuscular plane can be performed by either transabdominally (TA-RM) or via enhanced view totally extraperitoneal approach (eTEP). Although both techniques offer the mesh extension in the best anatomical space, closure of hernia defect, avoidance of traumatic fixation, the superiority of one approach over another is not established. This systematic review and meta-analysis were set up to analyze safety and efficacy of eTEP in comparison with TA-RM. Materials and Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) framework was used as guideline to conduct systematic search of literature. Studies that provided comparative data of MIS-VHR using eTEP versus TA-RM were identified. Primary outcomes were major complications. These were defined as grade III–IV according to Clavien–Dindo classification. Secondary outcomes included: surgical site infection (SSI) rates, seroma rates, surgical site occurrence requiring procedural intervention (SSOPI), minor complications (Clavien–Dindo grade I–II), intraoperative complications, recurrence rate, postoperative ileus, duration of surgery, postoperative pain. Random- and fixed-effects models of statistical analysis were used. Risk difference (RD) was computated for binary outcomes (major and minor complications, SSI, seroma, SSOPI, recurrence, ileus) with 95% confidence intervals. I 2 test was used to assess statistical heterogeneity. Risk of bias assessment was performed using Newcastle–Ottawa framework. Results: There were 3 observational studies that enrolled 370 participants. In the eTEP group there were 166 patients and, in the TA-RM group there were 204 patients. There was no significant RD with regard to major complications (RD −0.02 [−0.06 to 0.02], test for overall effect: Z = 0.86 [ P = .39]). There was no significant RD in occurrence of minor complications, SSI, seroma, SSOPI, recurrence, ileus. Conclusions: Both eTEP and TA-RM were found to have equal safety profile. Further high-quality studies evaluating patient reported outcomes and late recurrence may be useful. PROSPERO registration number: CRD42023429160.

17 February 2023 in Polish Journal of Surgery
Verified
Journal Article
Closed access
YTYegor Tryliskyy
Yegor Tryliskyy
VTVolodymyr Tyselskyi
Volodymyr Tyselskyi
AKAndrii Kebkalo
Andrii Kebkalo
NPNikita Ponomarov
Nikita Ponomarov
Introduction: This systematic review and meta-analysis analysed was set up to compare totally extraperitoneal mesh repair (TEP) and intraperitoneal onlay mesh placement (IPOM) in patients undergoing minimally invasive ventral hernia mesh surgery (MIS-VHMS). Aim: This systematic review and meta-analysis were set up to compare safety and effectiveness of eTEP and IPOM in patients undergoing MIVHMR. Methods: A systematic literature searches of three major databases were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to identify studies that compared two techniques of MIS-VHMS: TEP and IPOM. Primary outcome of interest was major complications post-operatively, defined as a composite outcome of surgical-site occurrences requiring procedural intervention (SSOPI), readmission to hospital, recurrence, reoperation or death. Secondary outcomes were intraoperative complications, duration of surgery, surgical site occurrence (SSO), SSOPI, postoperative ileus, post-operative pain. The risk of bias was assessed using Cohrane’s Risk of Bias tool 2 for randomized controlled trials (RCTs) and Newcastle-Ottawa score for observational studies (OSs). Results: Five OSs and two RCTs al including total number of 553 patients were included. There was no difference in primary outcome (RD 0.00 [-0.05, 0.06], p = 0.95), incidence of postoperative ileus. Operative time was longer in TEP (MD 40.10 [27.28, 52.91], p<0.01). TEP was found to be associated with less postoperative pain at 24h and 7 days after surgery. Conclusions: Both TEP and IPOM were detected to have equal safety profile and do not differ in SSO or SSOPI rates, incidence of postoperative ileus. TEP has longer operative time but provides better early postoperative pain outcomes. Further highquality studies with long follow up evaluating recurrence and patient reported outcomes are needed. Comparison of other transabdominal and extraperitoneal MIS-VHMS techniques is another direction of future research.